2020
DOI: 10.1016/j.ultrasmedbio.2020.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery

Abstract: Therapeutic ultrasound strategies that harness the mechanical activity of cavitation nuclei for beneficial tissue bio-effects are actively under development. The mechanical oscillations of circulating microbubbles, the most widely investigated cavitation nuclei, which may also encapsulate or shield a therapeutic agent in the bloodstream, trigger and promote localized uptake. Oscillating microbubbles can create stresses either on nearby tissue or in surrounding fluid to enhance drug penetration and efficacy in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
207
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 246 publications
(209 citation statements)
references
References 321 publications
(388 reference statements)
1
207
1
Order By: Relevance
“…Ultrasound exposure is known to increase cell membrane permeability and facilitate the delivery of drugs or genes into cells [ 18 , 19 ]. A combination of ultrasound exposure and microbubbles further increases cell membrane permeability even when using weak intensity ultrasound, leading to enhanced drug and gene uptake [ 12 , 13 , 14 , 15 , 16 , 17 ]. Stable oscillations of microbubbles are caused by exposure to low acoustic pressure, a process termed stable cavitation.…”
Section: Microbubbles and Nanobubblesmentioning
confidence: 99%
See 1 more Smart Citation
“…Ultrasound exposure is known to increase cell membrane permeability and facilitate the delivery of drugs or genes into cells [ 18 , 19 ]. A combination of ultrasound exposure and microbubbles further increases cell membrane permeability even when using weak intensity ultrasound, leading to enhanced drug and gene uptake [ 12 , 13 , 14 , 15 , 16 , 17 ]. Stable oscillations of microbubbles are caused by exposure to low acoustic pressure, a process termed stable cavitation.…”
Section: Microbubbles and Nanobubblesmentioning
confidence: 99%
“…In recent years, nanoscale contrast agents have been developed. Furthermore, micro- or nanobubbles have previously been investigated as site-specific drug or gene delivery tools [ 12 , 13 , 14 , 15 , 16 , 17 ]. To exploit the combination of ultrasound and bubbles both for diagnosis and therapeutics as a theranostic system, various types of bubbles valuable for systemic administration have been well documented in recent years.…”
Section: Introductionmentioning
confidence: 99%
“…Targeted microbubbles are employed for molecular imaging of inflammation, tumors, and cardiovascular disease [ 2 ]. Other types of microbubbles are being developed specifically for drug delivery [ 3 ]. All of these applications make use of the compression and expansion of the microbubble gas core upon ultrasound insonification.…”
Section: Introductionmentioning
confidence: 99%
“…The coating reduces surface tension and gas diffusion [ 7 ]. If phospholipids or polymers are used as microbubble coating, a ligand can be attached for molecular imaging [ 8 ], and they can be loaded with a drug for localized delivery [ 3 ]. The physicochemical properties of the microbubble coating, such as the shell elasticity and viscosity, are related to the acoustical properties, such as the resonance frequency and the damping coefficient [ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…[20] Administration of PFC-stabilized MBs in conjunction with US was deemed beneficial in several theranostic approaches that can combine diagnostic imaging and ablation, histotripsy, embolotherapy, radiotherapy, photo(sono)dynamic therapy, chemotherapy, gene delivery, including across the blood brain barrier, or anti-vascular therapy. [21][22][23][24][25] This short review, after briefly reminding the impeding effects of hypoxia on cancer therapies, reports recent advances that demonstrate the capacity for PFC-based NEs, P-SNEs, MBs and other PFC-based nanodevices to deliver oxygen to tumors and, thereby, efficiently fight hypoxia in O 2 -dependant cancer therapies.…”
Section: Introduction: Perfluorocarbons As O 2 Carriersmentioning
confidence: 99%